Riparian Pharmaceuticals' Incubator/Accelerator Round

Riparian Pharmaceuticals raised a round of funding on December 21, 2016. Investors include Harvard Life Lab.

Riparian Pharmaceuticals is exploring therapeutics that would modify the biology within blood vessel walls to help with cardiovascular, diabetic, and kidney diseases.…

Articles about Riparian Pharmaceuticals' Incubator/Accelerator Round: